C

Boogaerts, M. A., Van Hoof, A., Catovsk,y D., Kovacs, M., Montillo, M., Zinzani, P. L., Binet, J. L., Feremans, W., Marcus, R., Bosch, F., Verhoef, G., Klein, M. (2001) Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. JOURNAL OF CLINICAL ONCOLOGY, 19 (22). pp. 4252-4258. ISSN 0732-183X

Catovsky, D. (2004) Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 18 (4). pp. 783-794. ISSN 0889-8588

Catovsky, D., Swansbury, J. (2005) Del(9q) acute myeloid leukaemia: clinical and cytological characteristics and prognostic implications. BRITISH JOURNAL OF HAEMATOLOGY, 130 (6). p. 969. ISSN 0007-1048

Tsimberidou, A. M., Catovsky, D., Schlette, E., O'Brien, S., Wierda, W. G., Kantarjian, H., Garcia-Manero, G., Wen, S. J., Do, K. A., Lerner, S., Keating, M. J. (2006) Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. CANCER CYTOPATHOLOGY, 107 (1). pp. 125-135. ISSN 0008-543X

Binet, J. L., Caligaris-Cappio, F., Catovsky, D., Cheson, B., Davis, T., Dighiero, G., Dohner, H., Hallek, M., Hillmen, P., Keating, M., Montserrat, E., Kipps, T. J., Rai, K. (2006) Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. BLOOD, 107 (3). pp. 859-861. ISSN 0006-4971

Dearden, C., Wade, R., Else, M., Richards, S., Milligan, D., Hamblin, T., Catovsky, D., UK Natl Canc Res Inst NCRI Haemato, [Group Author], NCRI CLL Working Grp, [Group Author] (2008) The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. BLOOD, 111 (4). pp. 1820-1826. ISSN 0006-4971

Boyd, R. S., Adam, P. J., Patel, S., Loader, J. A., Berry, J., Redpath, N. T., Poyser, H. R., Fletcher, G. C., Burgess, N. A., Stamps, A. C., Hudson, L., Smith, P., Griffiths, M., Willis, T. G., Karran, E. L., Oscier, D. G., Catovsky, D., Terrett, J. A., Dyer, M. J. S. (2003) Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B. LEUKEMIA, 17 (8). pp. 1605-1612. ISSN 0887-6924

Thomas, R., Ribeiro, I., Shepherd, P., Johnson, P., Cook, M., Lakhani, A., Kaczmarski, R., Carrington, P., Catovsky, D. (2002) Spontaneous clinical regression in chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 116 (2). pp. 341-345. ISSN 0007-1048

Gotic, M., Cemerikic, V., Elezovic, I., Boskovic, D., Bila, J., Magic, Z., Jocic, D. J., Pavlovic, D., Grujicic, D., Stosic, T., Wotherspoon, A., Catovsky, D. (2005) Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia. LEUKEMIA & LYMPHOMA, 46 (5). pp. 765-769. ISSN 1042-8194

Yuille, M. R., Condie, A., Stone, E. M., Wilsher, J., Bradshaw, P. S., Brooks, L., Catovsky, D. (2001) TCL1 is activated by chromosomal rearrangement or by hypomethylation. GENES CHROMOSOMES & CANCER, 30 (4). pp. 336-341. ISSN 1045-2257

Dungarwalla, M., Appiah-Cubi, S., Kulkarni, S., Saso, R., Wotherspoon, A., Osuji, N., Swansbury, J., Cunningham, D. C., Catovsky, D., Dearden, C. E., Matutes, E. (2008) High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis. BRITISH JOURNAL OF HAEMATOLOGY, 143 (1). pp. 71-74. ISSN 0007-1048

Else, M., Dearden, C. E., Matutes, E., Garcia-Talavera, J., Rohatiner, A. Z. S., Johnson, S. A. N., O'Connor, N. T. J., Haynes, A., Osuji, N., Forconi, F., Lauria, F., Catovsky, D. (2009) Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. BRITISH JOURNAL OF HAEMATOLOGY, 145 (6). pp. 733-740. ISSN 0007-1048

Del Giudice, I., Osuji, N., Dexter, T., Brito-Babapulle, V., Parry-Jones, N., Chiaretti, S., Messina, M., Morgan, G., Catovsky, D., Matutes, E. (2009) B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures. LEUKEMIA, 23 (11). pp. 2160-2167. ISSN 0887-6924

Hockley, S. L., Morilla, A., Else, M., Dearden, C., Catovsky, D., Morgan, G. J., Matutes, E., Gonzalez, D. (2010) Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma. LEUKEMIA, 24 (5). pp. 1084-1086. ISSN 0887-6924

Okines, A. F. C., Asghar, U., Cunningham, D., Ashley, S., Ashton, J., Jackson, K., Hawkes, E., Chau, I. (2010) Rechallenge with Platinum plus Fluoropyrimidine +/- Epirubicin in Patients with Oesophagogastric Cancer. ONCOLOGY, 79 (1-2). pp. 150-158. ISSN 0030-2414

Baird, R., Biondo, A., Chhaya, V., McLachlan, J., Karpathakis, A., Rahman, S., Barbachano, Y., Cunningham, D., Chau, I. (2011) Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction. BRITISH JOURNAL OF CANCER, 104 (1). pp. 43-50. ISSN 0007-0920

Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., Wente, M. N., Izbicki, J. R., Friess, H., Lerch, M. M., Dervenis, C., Olah, A., Butturini, G., Doi, R., Lind, P. A., Smith, D., Valle, J. W., Palmer, D. H., Buckels, J. A., Thompson, J., McKay, C. J., Rawcliffe, C. L., Buechler, M. W., European Study Grp Pancreatic Canc, [Group Author] (2010) Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 304 (10). pp. 1073-1081. ISSN 0098-7484

Hawkes, E., Cunningham, D. (2010) Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer? LANCET ONCOLOGY, 11 (11). pp. 1020-1021. ISSN 1470-2045

Hawkes, E. A., Okines, A. F. C., Plummer, C., Cunningham, D. (2011) Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible. JOURNAL OF CLINICAL ONCOLOGY, 29 (18). E560-E562. ISSN 0732-183X

Van Cutsem, E., Kohne, C. H., Lang, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., Schlichting, M., Zubel, A., Celik, I., Rougier, P., Ciardiello, F. (2011) Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. JOURNAL OF CLINICAL ONCOLOGY, 29 (15). pp. 2011-2019. ISSN 0732-183X

Burton, C., Smith, P., Vaughan-Hudson, G., Qian, W., Hoskin, P., Cunningham, D., Hancock, B., Linch, D. (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 130 (4). pp. 536-541. ISSN 0007-1048

Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., Solal-Celigny, P., Offner, F., Walewski, J., Raposo, J., Jack, A., Smith, P. (2005) CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. BLOOD, 105 (4). pp. 1417-1423. ISSN 0006-4971

UNSPECIFIED (2001) The Effective Management of Non-Hodgkin's Lymphoma. Aesculapius Medical Press., London, UK. ISBN 978-190304411-7

Linch, D. C., Yung, L., Smith, P., Maclennan, K., Jack, A., Hancock, B., Cunningham, D., Hoskin, P., Qian, W., Holte, H., Boesen, A., Grigg, A., Browett, P., Trneny, M. (2010) Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients < 65 years with poor prognosis histologically aggressive NHL. BRITISH JOURNAL OF HAEMATOLOGY, 149 (2). pp. 237-243. ISSN 0007-1048

Hewish, M., Cunningham, D. (2011) First-line treatment of advanced colorectal cancer. LANCET, 377 (9783). pp. 2060-2062. ISSN 0140-6736

Yung, L., Cunningham, D., Hancock, B., Smith, P., Maclennan, K., Linch, D., McMillan, A. (2004) Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). BRITISH JOURNAL OF CANCER, 91 (4). pp. 695-698. ISSN 0007-0920

Okines, A., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., ESMO Guidelines Working Grp, [Group Author] (2010) Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 21 (Suppl.). v50-v54. ISSN 0923-7534

Sharma, R., Cunningham, D., Smith, P., Robertson, G., Dent, O., Clarke, S. J. (2009) Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients - analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO. BMC CANCER, 9. ISSN 1471-2407

Maisey N, Cunningham D. (2003) Lymphoma. In: Cancer in Primary Care. Martin Dunitz, London, UK, pp. 205-216. ISBN 978-190186526-4

Haque, S., Noble, J., Wotherspoon, A., Woodhouse, C., Cunningham, D. (2004) MALT lymphoma of the foreskin. LEUKEMIA & LYMPHOMA, 45 (8). pp. 1699-1701. ISSN 1042-8194

Mainwaring, P. N., Cunningham, D., Gregory, W., Hoskin, P., Hancock, B., Norton, A. J., MacLennan, K., Smith, P., Hudson, G. V., Linch, D. (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdfiaCEBO versus PMitCEBO. BLOOD, 97 (10). pp. 2991-2997. ISSN 0006-4971

Okines, A. F. C., Cunningham, D. (2010) Multimodality treatment for localized gastro-oesophageal cancer. ANNALS OF ONCOLOGY, 21 (Suppl.). pp. 286-293. ISSN 0923-7534

Bystricky, B., Okines, A. F. C., Cunningham, D. (2011) Optimal Therapeutic Strategies for Resectable Oesophageal or Oesophagogastric Junction Cancer. DRUGS, 71 (5). pp. 541-555. ISSN 0012-6667

Arkenau, H. T., Gordon, C., Murphy, F., Cunningham, D. (2007) Paraneoplastic syndrome: Subacute cerebellar degeneration in Hodgkin's disease. LEUKEMIA & LYMPHOMA, 48 (4). pp. 819-822. ISSN 1042-8194

Rao, S., Watkins, D., Cunningham, D., Dunlop, D., Johnson, P., Selby, P., Hancock, B. W., Fegan, C., Culligan, D., Schey, S., Morris, T. C. M., Lissitchkov, T., Oliver, J. W., Holmlund, J. T. (2004) Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma. ANNALS OF ONCOLOGY, 15 (9). pp. 1413-1418. ISSN 0923-7534

Marcus, R., Imrie, K., Solal-Celigny, P., Catalano, J. V., Dmoszynska, A., Raposo, J. C., Offner, F. C., Gomez-Codina, J., Belch, A., Cunningham, D., Wassner-Fritsch, E., Stein, G. (2008) Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 26 (28). pp. 4579-4586. ISSN 0732-183X

Burton, C., Linch, D., Hoskin, P., Milligan, D., Dyer, M. J. S., Hancock, B., Mouncey, P., Smith, P., Qian, W., MacLennan, K., Jack, A., Webb, A., Cunningham, D. (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. BRITISH JOURNAL OF CANCER, 94 (6). pp. 806-813. ISSN 0007-0920

Asghar, U., Hawkes, E., Cunningham, D. (2010) Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal Cancer. CLINICAL COLORECTAL CANCER, 9 (5). pp. 274-281. ISSN 1533-0028

Dewdney, A., Hawkes, E. A., Cunningham, D. (2011) Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply. JOURNAL OF CLINICAL ONCOLOGY, 29 (19). pp. 2737-2738. ISSN 0732-183X

Hawkes, E., Cunningham, D. (2010) Relationship Between Colorectal Cancer Biomarkers and Response to Epidermal Growth Factor Receptor Monoclonal Antibodies. JOURNAL OF CLINICAL ONCOLOGY, 28 (28). E529-E531. ISSN 0732-183X

Murphy, F., Sirohi, B., Cunningham, D. (2007) Stem cell transplantation in Hodgkin lymphoma. EXPERT REVIEWS IN ANTICANCER THERAPY, 7 (3). pp. 297-306. ISSN 1473-7140

Dickinson, M., Wotherspoon, A., Cunningham, D. (2006) Sub-clinical dissemination of follicular lymphoma in normal sized lymph nodes may not be detected by radiologic staging: a case of disseminated follicular lymphoma detected in nodal clearance as part of therapy for cutaneous melanoma. LEUKEMIA & LYMPHOMA, 47 (3). pp. 553-556. ISSN 1042-8194

Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., Ghaneh, P. (2007) Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. BRITISH JOURNAL OF CANCER, 96 (8). pp. 1183-1190. ISSN 0007-0920

Hawkes, E., Okines, A. F. C., Papamichael, D., Rao, S., Ashley, S., Charalambous, H., Koukouma, A., Chau, I., Cunningham, D. (2011) Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer. EUROPEAN JOURNAL OF CANCER, 47 (8). pp. 1146-1151. ISSN 0959-8049

Okines, A. F. C., Ashley, S. E., Cunningham, D., Oates, J., Turner, A., Webb, J., Saffery, C., Chua, Y. J., Chau, I. (2010) Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (25). pp. 3945-3950. ISSN 0732-183X

Hawkes, E. A., Cunningham, D., Tait, D., Brown, G., Chau, I. (2011) Neoadjuvant Chemotherapy Alone for Early-Stage Rectal Cancer: An Evolving Paradigm? SEMINARS IN RADIATION ONCOLOGY, 21 (3). pp. 196-202. ISSN 1053-4296

Gleeson, M., Hawkes, E. A., Peckitt, C., Wotherspoon, A., Attygalle, A., Sharma, B., Du, Y., Ethell, M., Potter, M., Dearden, C., Horwich, A., Chau, I., Cunningham, D. (2017) Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013. LEUKEMIA & LYMPHOMA, 58 (8). pp. 1805-1813. ISSN 1042-8194

Murthy, V., Thomas, K., Foo, K., Cunningham, D., Johnson, B., Norman, A., Horwich, A. (2008) Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: A phase II study. CLINICAL LYMPHOMA & MYELOMA, 8 (4). pp. 241-245. ISSN 1557-9190

Horwich, A., Cunningham, D. (2010) Lymphocyte-Predominant Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 28 (19). E325-E325. ISSN 0732-183X

Sirohi, B., Cunningham, D., Norman, A., Last, K., Chau, I., Horwich, A., Oates, J., Chong, G., Wotherspoon, A. (2007) Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL). HEMATOLOGY, 12 (2). pp. 149-153. ISSN 1024-5332

Sirohi, B., Cunningham, D., Powles, R., Murphy, F., Arkenau, T., Norman, A., Oates, J., Wotherspoon, A., Horwich, A. (2008) Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. ANNALS OF ONCOLOGY, 19 (7). pp. 1312-1319. ISSN 0923-7534

UNSPECIFIED (2004) The Effective Management of Non-Hodgkin's Lymphoma. Aesculapius Medical Press, London, UK. ISBN 978-190304437-7

Murray, P. V., O'Brien, M. E. R., Padhani, A. R., Powles, R., Cunningham, D., Jeanes, A., Ashley, S. (2001) Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. BONE MARROW TRANSPLANTATION, 27 (9). pp. 967-971. ISSN 0268-3369

D

Owen, R. G., Fan, I., O'Connor, S. J. M., Rollett, R. A., Child, J. A., Davies, F. E., Rawstron, A. C. (2007) Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target? BRITISH JOURNAL OF HAEMATOLOGY, 136 (1). pp. 163-164. ISSN 0007-1048

Milligan, D. W., Fernandes, S., Dasgupta, R., Davies, F. E., Matutes, E., Fegan, C. D., McConkey, C., Child, J. A., Cunningham, D., Morgan, G. J., Catovsky, D., for the National Cancer Research Institute (NCRI) Haematological Studies Group (2005) Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. BLOOD, 105 (1). pp. 397-404. ISSN 0006-4971

Walker, B. A., Wardell, C. P., Chiecchio, L., Smith, E. M., Boyd, K. D., Neri, A., Davies, F. E., Ross, F. M., Morgan, G. J. (2010) Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. BLOOD. ISSN 0006-4971

Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Kung, A. L., Davies, F. E., Morgan, G., Akiyama, M., Shringarpure, R., Munshi, N. C., Richardson, P. G., Hideshima, T., Chauhan, D., Gu, X. S., Bailey, C., Joseph, M., Libermann, T. A., Rosen, N. S., Anderson, K. C. (2006) Antimyeloma activity of heat shock protein-90 inhibition. BLOOD, 107 (3). pp. 1092-1100. ISSN 0006-4971

Schey, S. A., Morgan, G. J., Ramasamy, K., Hazel, B., Ladon, D., Corderoy, S., Jenner, M., Phekoo, K., Boyd, K., Davies, F. E. (2010) CD138 shedding in plasma cell myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 150 (3). pp. 326-333. ISSN 0007-1048

Rawstron, A. C., Laycock-Brown, G., Hale, G., Davies, F. E., Morgan, G. J., Child, J. A., Hillmen, P., Owen, R. G. (2006) CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 91 (11). pp. 1577-1578. ISSN 0390-6078

Davies, F. E., Wu, P., Jenner, M., Srikanth, M., Saso, R., Morgan, G. J. (2007) The combination of cyclophosphamide, velcade and dexamethasone (CVD) induces high response rates with comparable toxicity to velcade alone (V) and velcade plus dexamethasone (VD). HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92 (8). pp. 1149-1150. ISSN 0390-6078

Walker, B. A., Leone, P. E., Chiecchio, L., Dickens, N. J., Jenner, M. W., Boyd, K. D., Johnson, D. C., Gonzalez, D., Dagrada, G. P., Protheroe, R. K. M., Konn, Z. J., Stockley, D. M., Gregory, W. M., Davies, F. E., Ross, F. M., Morgan, G. J. (2010) A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. BLOOD, 116 (15). E56-E65. ISSN 0006-4971

Palumbo, A., Davies, F., Kropff, M., Blade, J., Delforge, M., da Costa, F. L., Garcia Sanz, R., Schey, S., Facon, T., Morgan, G., Moreau, P. (2010) Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma. ANNALS OF HEMATOLOGY, 89 (8). pp. 803-811. ISSN 0939-5555

Augustson, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A., Drayson, M. T. (2005) Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party. JOURNAL OF CLINICAL ONCOLOGY, 23 (36). pp. 9219-9226. ISSN 0732-183X

Jenner, M. W., Leone, P. E., Walker, B. A., Ross, F. M., Johnson, D. C., Gonzalez, D., Chiecchio, L., Cabanas, E. D., Dagrada, G. P., Nightingale, M., Protheroe, R. K. M., Stockley, D., Else, M., Dickens, N. J., Cross, N. C. R., Davies, F. E., Morgan, G. J. (2007) Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. BLOOD, 110 (9). pp. 3291-3300. ISSN 0006-4971

Spink, C. F., Gray, L. C., Davies, F. E., Morgan, G. J., Bidwell, J. L. (2007) Haplotypic structure across the I kappa B alpha gene (NFKB1A) and association with multiple myeloma. CANCER LETTERS, 246 (1-2). pp. 92-99. ISSN 0304-3835

Boyd, K. D., Walker, B. A., Wardell, C. P., Ross, F. M., Gregory, W. M., Davies, F. E., Morgan, G. J. (2010) High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma. LEUKEMIA & LYMPHOMA, 51 (11). pp. 2126-2129. ISSN 1042-8194

Dickens, N. J., Walker, B. A., Leone, P. E., Johnson, D. C., Brito, J. L., Zeisig, A., Jenner, M. W., Boyd, K. D., Gonzalez, D., Gregory, W. M., Ross, F. M., Davies, F. E., Morgan, G. J. (2010) Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome. CLINICAL CANCER RESEARCH, 16 (6). pp. 1856-1864. ISSN 1078-0432

Walker, B. A., Leone, P. E., Jenner, M. W., Li, C., Gonzalez, D., Johnson, D. C., Ross, F. M., Davies, F. E., Morgan, G. J. (2006) Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. BLOOD, 108 (5). pp. 1733-1743. ISSN 0006-4971

Rees-Unwin, K. S., Craven, R. A., Davenport, E., Hanrahan, S., Totty, N. F., Dring, A. M., Banks, R. E., Morgan, G. J., Davies, F. E. (2007) Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 139 (4). pp. 559-567. ISSN 0007-1048

El-Sherbiny, Y. M., Meade, J. L., Holmes, T. D., McGonagle, D., Mackie, S. L., Morgan, A. W., Cook, G., Feyler, S., Richards, S. J., Davies, F. E., Morgan, G. J., Cook, G. P. (2007) The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. CANCER RESEARCH, 67 (18). pp. 8444-8449. ISSN 0008-5472

Brito, J. L. R., Davies, F. E., Gonzalez, D., Morgan, G. J. (2008) Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells. JOURNAL OF IMMUNOLOGICAL METHODS, 333 (1-2). pp. 147-155. ISSN 0022-1759

Srikanth, M., Davies, F. E., Morgan, G. J. (2008) An update on drug combinations for treatment of myeloma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (1). pp. 1-12. ISSN 1354-3784

Bagratuni, T., Wu, P., de Castro, D. G., Davenport, E. L., Dickens, N. J., Walker, B. A., Boyd, K., Johnson, D. C., Gregory, W., Morgan, G. J., Davies, F. E. (2010) XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. BLOOD, 116 (2). pp. 250-253. ISSN 0006-4971

Davenport, E. L., Zeisig, A., Aronson, L. I., Moore, H. E., Hockley, S., Gonzalez, D., Smith, E. M., Powers, M. V., Sharp, S. Y., Workman, P., Morgan, G. J., Davies, F. E. (2010) Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma. LEUKEMIA, 24 (10). pp. 1804-1807. ISSN 0887-6924

Sriskandarajah, P., Dearden, C. E. (2017) Epidemiology and environmental aspects of marginal zone lymphomas. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 30 (1-2). pp. 84-91. ISSN 1521-6926

Schuh, A. H., Parry-Jones, N., Appleby, N., Bloor, A., Dearden, C. E., Fegan, C., Follows, G., Fox, C. P., Iyengar, S., Kennedy, B., McCarthy, H., Parry, H. M., Patten, P., Pettitt, A. R., Ringshausen, I., Walewska, R., Hillmen, P. (2018) Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). pp. 344-359. ISSN 0007-1048

Montillo, M., O'Brien, S., Tedeschi, A., Byrd, J. C., Dearden, C., Gill, D., Brown, J. R., Barrientos, J. C., Mulligan, S. P., Furman, R. R., Cymbalista, F., Plascencia, C., Chang, S., Hsu, E., James, D. F., Hillmen, P. (2017) Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study. Blood Cancer Journal, 7. ISSN 2044-5385

Barr, P. M., Brown, J. R., Hillmen, P., O'Brien, S., Barrientos, J. C., Reddy, N. M., Coutre, S., Mulligan, S. P., Jaeger, U., Furman, R. R., Cymbalista, F., Montillo, M., Dearden, C., Robak, T., Moreno, C., Pagel, J. M., Burger, J. A., Suzuki, S., Sukbuntherng, J., Cole, G., James, D. F., Byrd, J. C. (2017) Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL. Blood, 129 (19). pp. 2612-2615. ISSN 0006-4971

Barrientos, J. C., O'Brien, S., Brown, J. R., Kay, N. E., Reddy, N. M., Coutre, S., Tam, C., Mulligan, S., Jaeger, U., Devereux, S., Pocock, C., Robak, T., Schuster, S. J., Schuh, A., Gill, D., Bloor, A., Dearden, C., Moreno, C., Cull, G., Hamblin, M., Jones, J. A., Eckert, K., Solman, I. G., Suzuki, S., Hsu, E., James, D. F., Byrd, J. C., Hillmen, P. (2018) Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 18 (12). 803-813.. ISSN 2152-2650

Kreitman, R. J., Dearden, C., Zinzani, P. L., Delgado, J., Karlin, L., Robak, T., Gladstone, D. E., le Coutre, P., Dietrich, S., Gotic, M., Larratt, L., Offner, F., Schiller, G., Swords, R., Bacon, L., Bocchia, M., Bouabdallah, K., Breems, D. A., Cortelezzi, A., Dinner, S., Doubek, M., Gjertsen, B. T., Gobbi, M., Hellmann, A., Lepretre, S., Maloisel, F., Ravandi, F., Rousselot, P., Rummel, M., Siddiqi, T., Tadmor, T., Troussard, X., Yi, C. A., Saglio, G., Roboz, G. J., Balic, K., Standifer, N., He, P., Marshall, S., Wilson, W., Pastan, I., Yao, N. S., Giles, F. (2018) Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. LEUKEMIA, 32 (8). pp. 1768-1777. ISSN 0887-6924

Sud, A., Dearden, C. (2017) T-cell Prolymphocytic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 31 (2). pp. 273-283. ISSN 0889-8588

F

Bodi, I., Gonzalez, D., Epaliyange, P., Gullan, R., Fisher, C. (2009) Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion. NEUROPATHOLOGY, 29 (4). pp. 460-465. ISSN 0919-6544

Patel, N., Goff, L. K., Clark, T., Ford, A. M., Foot, N., Lillington, D., Hing, S., Pritchard-Jones, K., Jones, L. K., Saha, V. (2003) Expression profile of wild-type ETV6 in childhood acute leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 122 (1). pp. 94-98. ISSN 0007-1048

H

Warde, P., Specht, L., Horwich, A., Oliver, T., Panzarella, T., Gospodarowicz, M., von der Maase, H. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. JOURNAL OF CLINICAL ONCOLOGY, 20 (22). pp. 4448-4452. ISSN 0732-183X

Jackson, C., Sirohi, B., Cunningham, D., Horwich, A., Thomas, K., Wotherspoon, A. (2010) Lymphocyte-predominant Hodgkin lymphoma-clinical features and treatment outcomes from a 30-year experience. ANNALS OF ONCOLOGY, 21 (10). pp. 2061-2068. ISSN 0923-7534

Arkenau, H. T., Chong, G., Cunningham, D., Watkins, D., Agarwal, R., Sirohi, B., Trumper, M., Norman, A., Wotherspoon, A., Horwich, A. (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. ANNALS OF ONCOLOGY, 18 (3). pp. 541-545. ISSN 0923-7534

Shahidi, M., Kamangari, N., Ashley, S., Cunningham, D., Horwich, A. (2006) Site of relapse after chemotherapy atone for stage I and II Hodgkin's disease. RADIOTHERAPY AND ONCOLOGY, 78 (1). pp. 1-5. ISSN 0167-8140

Ng, M., Waters, J., Cunningham, D., Chau, I., Horwich, A., Hill, M., Norman, A. R., Wotherspoon, A., Catovsky, D. (2005) Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. BRITISH JOURNAL OF CANCER, 92 (8). pp. 1352-1357. ISSN 0007-0920

Shah, V., Boyd, K. D., Houlston, R. S., Kaiser, M. F. (2017) Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report. BMC CANCER, 17. ISSN 1471-2407

White, S. M., Morgan, A., Da Costa, A., Lacombe, D., Knight, S. J. L., Houlston, R., Whiteford, M. L., Newbury-Ecob, R. A., Hurst, J. A. (2010) The Phenotype of Floating-Harbor Syndrome in 10 Patients. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 152A (4). pp. 821-829. ISSN 1552-4825

Yuille, M., Condie, A., Hudson, C., Kote-Jarai, Z., Stone, E., Eeles, R., Matutes, E., Catovsky, D., Houlston, R. (2002) Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. BLOOD, 99 (11). pp. 4216-4218. ISSN 0006-4971

Rudd, M. F., Sellick, G. S., Allinson, R., Matutes, E., Catovsky, D., Houlston, R. S. (2004) MTHFR polymorphisms and risk of chronic lymphocytic leukemia. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 13 (12). pp. 2268-2270. ISSN 1055-9965

Rawstron, A. C., Yuille, M. R., Fuller, J., Cullen, M., Kennedy, B., Richards, S. J., Jack, A. S., Matutes, E., Catovsky, D., Hillmen, P., Houlston, R. S. (2002) Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. BLOOD, 100 (7). pp. 2289-2290. ISSN 0006-4971

Condie, A., Powles, R. L., Hudson, C. D., Shepherd, V., Bevan, S., Yuille, M. R., Houlston, R. S. (2002) Analysis of the Fanconi anaemia complentation group A gene in acute myeloid leukaemia. LEUKEMIA & LYMPHOMA, 43 (9). pp. 1849-1853. ISSN 1042-8194

Schwarz, A. J., Maisey, N. R., Collins, D. J., Cunningham, D., Huddart, R., Leach, M. O. (2002) Early in vivo detection of metabolic response: a pilot study of H-1 MR spectroscopy in extracranial lymphoma and germ cell tumours. BRITISH JOURNAL OF RADIOLOGY, 75 (900). pp. 959-966. ISSN 0007-1285

Sharma, R. A., Wotherspoon, A. C., Cook, G., Morgan, G. J., Huddart, R. A. (2006) Neuron-specific enolase expression in multiple myeloma. LANCET ONCOLOGY, 7 (11). p. 960. ISSN 1470-2045

K

Chau, I., Harries, M., Cunningham, D., Hill, M., Ross, P. J., Archer, C. D., Norman, A. R., Wotherspoon, A., Koh, D. M., Gill, K., Uzzell, M., Prior, Y., Catovsky, D. (2003) Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 120 (6). pp. 970-977. ISSN 0007-1048

L

Prescot, A. P., Dzik-Jurasz, A. S. K., Leach, M. O., Sirohi, L., Powles, R., Collins, D. J. (2005) Localized COSY and DQF-COSY H-1-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia. JOURNAL OF MAGNETIC RESONANCE IMAGING, 22 (4). pp. 541-548. ISSN 1053-1807

M

Dearden, C. E., Matutes, E. (2006) Alemtuzumab in T-cell lymphoproliferative disorders. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 19 (4). pp. 795-810. ISSN 1521-6926

Dearden, C. E., Matutes, E., Catovsky, D. (2002) Alemtuzumab in T-cell malignancies. MEDICAL ONCOLOGY, 19 (Supple). S27-S32. ISSN 1357-0560

Skowronska, A., Austen, B., Powell, J. E., Weston, V., Oscier, D. G., Dyer, M. J. S., Matutes, E., Pratt, G., Fegan, C., Moss, P., Taylor, M. A., Stankovic, T. (2012) ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97 (1). pp. 142-146. ISSN 0390-6078

Tso, A. C. Y., Olavarria, E., Matutes, E., Bain, B. J. (2007) Case 33. Diagnostic difficulty in a patient with acute leukemia. LEUKEMIA & LYMPHOMA, 48 (1). pp. 177-179. ISSN 1042-8194

Lemez, P., Attarbaschi, A., Bene, M. C., Bertrand, Y., Castoldi, G., Forestier, E., Garand, R., Haas, O. A., Kagialis-Girard, S., Ludwig, W., Matutes, E., Mejstrikova, E., Pages, M., Pickl, W., Porwit, A., Orfao, A., Schabath, R., Stary, J., Strobl, H., Talmant, P., van't Veer, M. B., Zemanova, Z., European Grp Immunological Charact, [Group Author] (2010) Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases. EUROPEAN JOURNAL OF HAEMATOLOGY, 85 (4). pp. 300-308. ISSN 0902-4441

Krishnan, B., Matutes, E., Dearden, C. (2006) Prolymphocytic leukemias. SEMINARS IN ONCOLOGY, 33 (2). pp. 257-263. ISSN 0093-7754

Beer, P., Abdalla, S. H., Matutes, E., Bain, B. J. (2005) Teaching cases from the Royal Marsden and St Mary's Hospital case 29: Striking generalized lymphadenopathy in 'acute myeloid leukemia'. LEUKEMIA & LYMPHOMA, 46 (1). pp. 155-156. ISSN 1042-8194

Patel, K. C., Bain, B. J., Matutes, E., Catovsky, D. (2002) Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 22: An unusual cause of lymphocytosis. LEUKEMIA & LYMPHOMA, 43 (4). pp. 923-925. ISSN 1042-8194

Scolnik, M. P., Morilla, R., de Bracco, M. M. D., Catovsky, D., Matutes, E. (2002) CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease. LEUKEMIA RESEARCH, 26 (7). pp. 615-619. ISSN 0145-2126

Osuji, N., Beiske, K., Randen, U., Matutes, E., Tjonnfjord, G., Catovsky, D., Wotherspoon, A. (2007) Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. HISTOPATHOLOGY, 50 (5). pp. 547-554. ISSN 0309-0167

Sah, S. P., Matutes, E., Wotherspoon, A. C., Morilla, R., Catovsky, D. (2003) A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. JOURNAL OF CLINICAL PATHOLOGY, 56 (2). pp. 129-132. ISSN 0021-9746

Elnenaei, M. O., Jadayel, D. M., Matutes, E., Morilla, R., Owusu-Ankomah, K., Atkinson, S., Titley, I., Mandala, E. M., Catovsky, D. (2001) Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. LEUKEMIA RESEARCH, 25 (2). pp. 115-123. ISSN 0145-2126

Parry-Jones, N., Matutes, E., Morilla, R., Brito-Babapulle, V., Wotherspoon, A., Swansbury, G. J., Catovsky, D. (2007) Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH. BRITISH JOURNAL OF HAEMATOLOGY, 137 (2). pp. 117-124. ISSN 0007-1048

Del Giudice, F., Matutes, E., Osuji, N., Parry-Jones, N., Swansbury, J., Catovsky, D. (2005) Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waidenstrom's macroglobulinemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 90 (2). pp. 268-270. ISSN 0390-6078

Brito-Babapulle, V., Baou, M., Matutes, E., Morilla, R., Atkinson, S., Catovsky, D. (2001) Deletions of D13S25, D13S319 and RB-1 mapping to 13q14.3 in T-cell prolymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 114 (2). pp. 327-332. ISSN 0007-1048

Delgado, J., Matutes, E., Morilla, A. M., Morilla, R. M., Owusu-Ankomah, K. A., Rafiq-Mohammed, F., del Giudice, I., Catovsky, D. (2003) Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 120 (5). pp. 754-759. ISSN 0002-9173

Osuji, N. C., Del Giudice, I., Matutes, E., Wotherspoon, A. C., Dearden, C., Catovsky, D. (2005) The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 90 (10). pp. 1435-1436. ISSN 0390-6078

Osuji, N., Fearfield, L., Matutes, E., Wotherspoon, A. C., Bunker, C., Catovsky, D. (2003) Granulomatous slack skin disease - disease features and response to pentostatin. BRITISH JOURNAL OF HAEMATOLOGY, 123 (2). pp. 297-304. ISSN 0007-1048

Thornton, P. D., Matutes, E., Bosanquet, A. G., Lakhani, A. K., Grech, H., Ropner, J. E., Joshi, R., Mackie, P. H., Douglas, I. D. C., Bowcock, S. J., Catovsky, D. (2003) High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. ANNALS OF HEMATOLOGY, 82 (12). pp. 759-765. ISSN 0939-5555

Milligan, D. W., Kochethu, G., Dearden, C., Matutes, E., MacConkey, C., Catovsky, D., NCRI Haematological Studies Grp, [Group Author] (2006) High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 133 (2). pp. 173-175. ISSN 0007-1048

Dearden, C. E., Matutes, E., Cazin, B., Tjonnfjord, G. E., Parreira, A., Nomdedeu, B., Leoni, P., Clark, F. J., Radia, D., Rassam, S. M. B., Roques, T., Ketterer, N., Brito-Babapulle, V., Dyer, M. J. S., Catovsky, D. (2001) High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. BLOOD, 98 (6). pp. 1721-1726. ISSN 0006-4971

Osuji, N., Matutes, E., Catovsky, D., Lampert, I., Wotherspoon, A. (2005) Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia - A comparative review. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 29 (7). pp. 935-941. ISSN 0147-5185

Else, M., Ruchlemer, R., Osuji, N., Del Giudice, I., Matutes, E., Woodman, A., Wotherspoon, A., Swansbury, J., Dearden, C., Catovsky, D. (2005) Long remissions in hairy cell leukemia with purine analogs - A report of 219 patients with a median follow-up of 12.5 years. CANCER CYTOPATHOLOGY, 104 (11). pp. 2442-2448. ISSN 0008-543X

Maravelaki, S., Burford, A., Wotherspoon, A., Joshi, R., Matutes, E., Catovsky, D., Brito-Babapulle, V. (2004) Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q 13) region. CANCER GENETICS AND CYTOGENETICS, 154 (1). pp. 67-71. ISSN 0165-4608

Solenthaler, M., Matutes, E., Brito-Babapulle, V., Morilla, R., Catovsky, D. (2002) p53 and mdm2 in mantle cell lymphoma in leukemic phase. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 87 (11). pp. 1141-1150. ISSN 0390-6078

Parry-Jones, N., Matutes, E., Gruszka-Westwood, A. M., Swansbury, G. J., Wotherspoon, A. C., Catovsky, D. (2003) Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. BRITISH JOURNAL OF HAEMATOLOGY, 120 (5). pp. 759-764. ISSN 0007-1048

Osuji, N., Matutes, E., Morilla, A., Del Giudice, I., Wotherspoon, A., Catovsky, D. (2005) Prolonged treatment response in aggressive natural killer cell leukemia. LEUKEMIA & LYMPHOMA, 46 (5). pp. 757-763. ISSN 1042-8194

Thornton, P. D., Bellas, C., Santon, A., Shah, G., Pocock, C., Wotherspoon, A. C., Matutes, E., Catovsky, D. (2005) Richter's transformation of chronic lymphocytic leukemia - The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. LEUKEMIA RESEARCH, 29 (4). pp. 389-395. ISSN 0145-2126

Ruchlemer, R., Wotherspoon, A. C., Thompson, J. N., Swansbury, J. G., Matutes, E., Catovsky, D. (2002) Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 118 (4). pp. 952-958. ISSN 0007-1048

Huh, Y. O., Abruzzo, L. V., Rassidakis, G. Z., Parry-Jones, N., Schlette, E., Brito-Bapabulle, V., Matutes, E., Wotherspoon, A., Keating, M. J., Medeiros, L. J., Catovsky, D. (2007) The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. BRITISH JOURNAL OF HAEMATOLOGY, 136 (2). pp. 220-228. ISSN 0007-1048

Matutes, E., Wotherspoon, A. C., Parker, N. E., Osuji, N., Isaacson, P. G., Catovsky, D. (2001) Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 115 (4). pp. 801-806. ISSN 0007-1048

Brito-Babapulle, V., Gruszka-Westwood, A. M., Platt, G., Andersen, C. L., Elnenaei, M. O., Matutes, E., Wotherspoon, A. C., Weston-Smith, S. G., Catovsky, D. (2002) Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 87 (4). pp. 357-362. ISSN 0390-6078

Catovsky, D., Matutes, E., Dearden, C., Osujl, N., Brito-Babapulle, V. (2004) The WHO classification of mature T-cell leukemias. BLOOD, 104 (9). pp. 2989-2990. ISSN 0006-4971

Thornton, P. D., Fernandez, C., Giustolisi, G. M., Morilla, R., Atkinson, S., A'Hern, R. P., Matutes, E., Catovsky, D. (2004) CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. THE HEMATOLOGY JOURNAL, 5 (2). pp. 145-151. ISSN 1466-4860

Matutes, E., Parry-Jones, N., Brito-Babapulle, V., Wotherspoon, A., Morilla, R., Atkinson, S., Elnenaei, M. O., Jain, P., Giustolisi, G. M., A'Hern, R. P., Catovsky, D. (2004) The leukemic presentation of mantle-cell lymphoma: Disease features and prognostic factors in 58 patients. LEUKEMIA & LYMPHOMA, 45 (10). pp. 2007-2015. ISSN 1042-8194

Del Giudice, I., Morilla, A., Osuji, N., Matutes, E., Morilla, R., Burford, A., Maravelaki, S., Owusu-Ankomah, K., Swansbury, J., A'Hern, R., Brito-Babapulle, V., Catovsky, D. (2005) zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. CANCER CYTOPATHOLOGY, 104 (10). pp. 2124-2132. ISSN 0008-543X

Thornton, P. D., Gruszka-Westwood, A. M., Hamoudi, R. A., Atkinson, S., Kaczmarek, P., Morilla, R. M., Hilditch, B. L., A'Hern, R., Matutes, E., Catovsky, D. (2004) Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. THE HEMATOLOGY JOURNAL, 5 (1). pp. 47-54. ISSN 1466-4860

Elnenaei, M. O., Hamoudi, R. A., Swansbury, J., Gruszka-Westwood, A. M., Brito-Babapulle, V., Matutes, E., Catovsky, D. (2003) Delineation of the minimal region of loss at 13q14 in multiple myeloma. GENES CHROMOSOMES & CANCER, 36 (1). pp. 99-106. ISSN 1045-2257

Gruszka-Westwood, A. M., Hamoudi, R. A., Matutes, E., Tuset, E., Catovsky, D. (2001) p53 abnormalities in splenic lymphoma with villous lymphocytes. BLOOD, 97 (11). pp. 3552-3558. ISSN 0006-4971

Arkenau, H. T., Chong, G., Cunningham, D., Watkins, D., Sirohi, B., Chau, I., Wotherspoon, A., Norman, A., Horwich, A., Matutes, E. (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92 (2). pp. 271-272. ISSN 0390-6078

Hockley, S. L., Giannouli, S., Morilla, A., Wotherspoon, A., Morgan, G. J., Matutes, E., Gonzalez, D. (2010) Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. BRITISH JOURNAL OF HAEMATOLOGY, 148 (4). pp. 666-669. ISSN 0007-1048

Elnenaei, M. O., Gruszka-Westwood, A. M., A'Hern, R., Matutes, E., Sirohi, B., Powles, R., Catovsky, D. (2003) Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 88 (5). pp. 529-537. ISSN 0390-6078

Ross, F. M., Ibrahim, A. H., Vilain-Holmes, A., Winfield, M. O., Chiecchio, L., Protheroe, R. K. M., Strike, P., Gunasekera, J. L., Jones, A., Harrison, C. J., Morgan, G. J., Cross, N. C. P. (2005) Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma. LEUKEMIA, 19 (9). pp. 1634-1642. ISSN 0887-6924

Morgan, G., Lipton, A. (2010) Antitumor Effects and Anticancer Applications of Bisphosphonates. SEMINARS IN ONCOLOGY, 37 (5, Sup). S30-S40. ISSN 0093-7754

Spink, C. F., Keen, L. J., Mensah, F. K., Law, G. R., Bidwell, J. L., Morgan, G. J. (2006) Association between non-Hodgkin lymphoma and haplotypes in the TNF region. BRITISH JOURNAL OF HAEMATOLOGY, 133 (3). pp. 293-300. ISSN 0007-1048

Schey, S., Brown, S. R., Tillotson, A. L., Yong, K., Williams, C., Davies, F., Morgan, G., Cavenagh, J., Cook, G., Cook, M., Orti, G., Morris, C., Sherratt, D., Flanagan, L., Gregory, W., Cavet, J., Myeloma, U. K. Early Phase Clinical (2015) Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial. BRITISH JOURNAL OF HAEMATOLOGY, 170 (3). pp. 336-348. ISSN 0007-1048

Grey-Davies, E., Bosworth, J. L., Boyd, K. D., Ebdon, C., Saso, R., Chitnavis, D., Mercieca, J. E., Morgan, G. J., Davies, F. E. (2012) Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 156 (4). pp. 552-555. ISSN 0007-1048

Morgan, G. J., Alvares, C. L. (2005) Benzene and the hemopoietic stem cell. CHEMICO-BIOLOGICAL INTERACTIONS, 153-15. pp. 217-222. ISSN 0009-2797

Smith, M. T., Skibola, C. F., Allan, J. M., Morgan, G. J. (2004) Causal models of leukaemia and lymphoma. IARC SCIENTIFIC PUBLICATIONS (157). pp. 373-392. ISSN 0300-5038

Kyle, R. A., Child, J. A., Anderson, K., Barlogie, B., Bataille, R., Bensinger, W., Blade, J., Boccadoro, M., Dalton, W., Dimopoulos, M., Djulbegovic, B., Drayson, M., Durie, B., Facon, T., Fonseca, R., Gahrton, G., Greipp, P., Harousseau, J. L., Harrington, D., Hussein, M., Joshua, D., Ludwig, H., Morgan, G., Oken, M., Powles, R., Richardson, P., Roodman, D., San Miguel, J., Shimizu, K., Shustik, C., Sirohi, B., Sonneveld, P., Tricot, G., Turesson, I., Van Ness, B., Vesole, D., Weber, D., Westin, J., Wheatley, K., Int Myeloma Working, Grp (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. BRITISH JOURNAL OF HAEMATOLOGY, 121 (5). pp. 749-757. ISSN 0007-1048

Ludwig, H., Beksac, M., Blade, J., Boccadoro, M., Cavenagh, J., Cavo, M., Dimopoulos, M., Drach, J., Einsele, H., Facon, T., Goldschmidt, H., Harousseau, J., Hess, U., Ketterer, N., Kropff, M., Mendeleeva, L., Morgan, G., Palumbo, A., Plesner, T., San Miguel, J., Shpilberg, O., Sondergeld, P., Sonneveld, P., Zweegman, S. (2010) Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective. ONCOLOGIST, 15 (1). pp. 6-25. ISSN 1083-7159

Chiecchio, L., Protheroe, R. K. M., Ibrahim, A. H., Cheung, K. L., Rudduck, C., Dagrada, G. P., Cabanas, E. D., Parker, T., Nightingale, M., Wechalekar, A., Orchard, K. H., Harrison, C. J., Cross, N. C. P., Morgan, G. J., Ross, F. M., UK Myeloma Forum, [Group Author] (2006) Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. LEUKEMIA, 20 (9). pp. 1610-1617. ISSN 0887-6924

Ayliffe, M. J., Davies, F. E., De Castro, D., Morgan, G. J. (2007) Demonstration of changes in plasma cell subsets in multiple myeloma. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92 (8). pp. 1135-1138. ISSN 0390-6078

Morris, C., Drake, M., Apperley, J., Iacobelli, S., van Biezen, A., Bjorkstrand, B., Goldschmidt, H., Harousseau, J., Morgan, G., de Witte, T., Niederwieser, D., Gahrton, G., Myeloma Subcomm Chronic Leukaemia, [Group Author] (2010) Efficacy and outcome of autologous transplantation in rare myelomas. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95 (12). pp. 2126-2133. ISSN 0390-6078

Hiwarkar, P., Arkenau, H. T., Treleaven, J., Morgan, G., Potter, M., Ethell, M. (2008) The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma. LEUKEMIA, 22 (8). pp. 1627-1629. ISSN 0887-6924

Dasgupta, R. K., Rule, S., Johnson, P., Davies, J., Burnett, A., Poynton, C., Wilson, K., Smith, G. M., Jackson, G., Richardson, C., Wareham, E., Stars, A. C., Tollerfield, S. M., Morgan, G. J. (2006) Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect. BONE MARROW TRANSPLANTATION, 37 (5). pp. 455-461. ISSN 0268-3369

Morgan, G. (2010) Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies. BLOOD REVIEWS, 24 (Suppl.). S27-S32. ISSN 0268-960X

Durie, B. G. M., Van Ness, B., Ramos, C., Stephens, O., Haznadar, M., Hoering, A., Haessler, J., Katz, M. S., Mundy, G. R., Kyle, R. A., Morgan, G. J., Crowley, J., Barlogie, B., Shaughnessy Jr., J. (2009) Genetic polymorphisms of EPHX1, Gsk3 beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma. LEUKEMIA, 23 (10). pp. 1913-1919. ISSN 0887-6924

Rothman, N., Skibola, C. F., Wang, S. S., Morgan, G., Lon, Q., Smith, M. T., Spinelli, J. J., Willett, E., De Sanjose, S., Cocco, P., Berndt, S. I., Brennan, P., Brooks-Wilson, A., Wacholder, S., Becker, N., Hartge, P., Zheng, T. Z., Roman, E., Holly, E. A., Boffetta, P., Armstrong, B., Cozen, W., Linet, M., Bosch, F. X., Ennas, M. G., Holford, T. R., Gallagher, R. P., Rollinson, S., Bracci, P. M., Cerhan, J. R., Whitby, D., Moore, P. S., Leaderer, B., Lai, A., Spink, C., Davis, S., Bosch, R., Scarpa, A., Zhang, Y. W., Severson, R. K., Yeager, M., Chanock, S., Nieters, A. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. LANCET ONCOLOGY, 7 (1). pp. 27-38. ISSN 1470-2045

Allan, J. M., Smith, A. G., Wheatley, K., Hills, R. K., Travis, L. B., Hill, D. A., Swirsky, D. M., Morgan, G. J., Wild, C. P. (2004) Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. BLOOD, 104 (13). pp. 3872-3877. ISSN 0006-4971

Van Ness, B., Ramos, C., Haznadar, M., Hoering, A., Haessler, J., Crowley, J., Jacobus, S., Oken, M., Rajkumar, V., Greipp, P., Barlogie, B., Durie, B., Katz, M., Atluri, G., Fang, G., Gupta, R., Steinbach, M., Kumar, V., Mushlin, R., Johnson, D., Morgan, G. (2008) Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC MEDICINE, 6. ISSN 1741-7015

Dring, A. M., Davies, F. E., Fenton, J. A. L., Roddam, P. L., Scott, K., Gonzalez, D., Rollinson, S., Rawstron, A. C., Rees-Unwin, K. S., Li, C., Munshi, N. C., Anderson, K. C., Morgan, G. J. (2004) A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma. CLINICAL CANCER RESEARCH, 10 (17). pp. 5692-5701. ISSN 1078-0432

Mensah, F. K., Gilthorpe, M. S., Davies, C. E., Keen, L. J., Adamson, P. J., Roman, E., Morgan, G. J., Bidwell, J. L., Law, G. R. (2007) Haplotype uncertainty in association studies. GENETIC EPIDEMIOLOGY, 31 (4). pp. 348-357. ISSN 0741-0395

Rollinson, S., Kesby, H., Morgan, G. J. (2006) Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma. LEUKEMIA & LYMPHOMA, 47 (12). pp. 2567-2583. ISSN 1042-8194

Tapper, W., Chiecchio, L., Dagrada, G. P., Konn, Z. J., Stockley, D. M., Szubert, A. J., Gregory, W. M., Bell, S. E., Jackson, G. H., Child, J. A., Morgan, G. J., Ross, F. M. (2011) Heterogeneity in the Prognostic Significance of 12p Deletion and Chromosome 5 Amplification in Multiple Myeloma. JOURNAL OF CLINICAL ONCOLOGY, 29 (2). E37-E39. ISSN 0732-183X

Gonzalez, D., van der Burg, M., Garcia-Sanz, R., Fenton, J. A., Langerak, A. W., Gonzalez, M., van Dongen, J. J. M., Miguel, J. F. S., Morgan, G. J. (2007) Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. BLOOD, 110 (9). pp. 3112-3121. ISSN 0006-4971

Ludwig, H., Durie, B. G. M., McCarthy, P., Palumbo, A., Miguel, J. S., Barlogie, B., Morgan, G., Sonneveld, P., Spencer, A., Andersen, K. C., Facon, T., Stewart, K. A., Einsele, H., Mateos, M. V., Wijermans, P., Waage, A., Beksac, M., Richardson, P. G., Hulin, C., Niesvizky, R., Lokhorst, H., Landgren, O., Bergsagel, P. L., Orlowski, R., Hinke, A., Cavo, M., Attal, M., Int Myeloma Working, Grp (2012) IMWG consensus on maintenance therapy in multiple myeloma. BLOOD, 119 (13). pp. 3003-3015. ISSN 0006-4971

Durie, B. G. M., Harousseau, J. L., Miguel, J. S., Blade, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., Ludwig, H., Gahrton, G., Beksac, M., Crowley, J., Belch, A., Boccadaro, M., Turesson, I., Joshua, D., Vesole, D., Kyle, R., Alexanian, R., Tricot, G., Attal, M., Merlini, G., Powles, R., Richardson, P., Shimizu, K., Tosi, P., Morgan, G., Rajkumar, S. V., Internatl Myeloma Working Grp, [Group Author] (2006) International uniform response criteria for multiple myeloma. LEUKEMIA, 20 (9). pp. 1467-1473. ISSN 0887-6924

Palumbo, A., Miguel, J. S., Sonneveld, P., Moreau, P., Drach, J., Morgan, G., Einsele, H. (2008) Lenalidomide: A new therapy for multiple myeloma. CANCER TREATMENT REVIEWS, 34 (3). pp. 283-291. ISSN 0305-7372

Durie, B. G. M., Kyle, R. A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Child, J. A., Comenzo, R., Djulbegovic, B., Fantl, D., Gahrton, G., Harousseau, J. L., Hungria, V., Joshua, D., Ludwig, H., Mehta, J., Morales, A. R., Morgan, G., Nouel, A., Oken, M., Powles, R., Roodman, D., San Miguel, J., Shimizu, K., Singhal, S., Sirohi, B., Sonneveld, P., Tricot, G., Van Ness, B. (2004) Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation (vol 5, pg 285, 2004). [Correction]

Ambrosone, C. B., Rebbeck, T. R., Morgan, G. J., Albain, K. S., Calle, E. E., Evans, W. E., Hayes, D. F., Kushi, L. H., McLeod, H. L., Rowland, J. H., Ulrich, C. M. (2006) New developments in the epidemiology of cancer prognosis: Traditional and molecular predictors of treatment response and survival. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 15 (11). pp. 2042-2046. ISSN 1055-9965

Krishnan, B., Morgan, G. J. (2007) Non-Hodgkin lymphoma secondary to cancer chemotherapy. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 16 (3). pp. 377-380. ISSN 1055-9965

Willett, E. V., Skibola, C. F., Adamson, P., Skibola, D. R., Morgan, G. J., Smith, M. T., Roman, E. (2005) Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. BRITISH JOURNAL OF CANCER, 93 (7). pp. 811-816. ISSN 0007-0920

Gahrton, G., Iacobelli, S., Bandini, G., Bjorkstrand, B., Corradini, P., Crawley, C., Hegenbart, U., Morgan, G., Kroger, N., Schattenberg, A., Schonland, S. O., Verdonck, L. F., Volin, L., de Witte, T., Niederwieser, D., Myeloma Subcommittee EBMT, [Group Author] (2007) Peripheral blood or bone marrow cells myeloablative conditioning allogeneic transplantation for multiple myeloma. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92 (11). pp. 1513-1518. ISSN 0390-6078

Worrillow, L. J., Smith, A. G., Scott, K., Andersson, M., Ashcroft, A. J., Dores, G. M., Glimelius, B., Holowaty, E., Jackson, G. H., Jones, G. L., Lynch, C. F., Morgan, G., Pukkala, E., Scott, D., Storm, H. H., Taylor, P. R., Vyberg, M., Willett, E., Travis, L. B., Allan, J. M. (2008) Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma. JOURNAL OF MEDICAL GENETICS, 45 (3). pp. 142-146. ISSN 0022-2593

Pratt, G., Fenton, J. A. L., Allsup, D., Fegan, C., Morgan, G. J., Jackson, G., Sunter, N. J., Hall, A. G., Irving, J. A. E., Allan, J. M. (2010) A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 150 (3). pp. 371-373. ISSN 0007-1048

Skibola, C. F., Lightfoot, T., Agana, L., Smith, A., Rollinson, S., Kao, A., Adamson, P., Morgan, G. J., Smith, M. T., Roman, E. (2005) Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 129 (5). pp. 618-621. ISSN 0007-1048

Lightfoot, T. J., Skibola, C. F., Smith, A. G., Forrest, M. S., Adamson, P. J., Morgan, G. J., Bracci, P. M., Roman, E., Smith, M. T., Holly, E. A. (2006) Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 91 (9). pp. 1222-1227. ISSN 0390-6078

Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., Miguel, J. S., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., Attal, M., Belch, A., Knop, S., Joshua, D., Sezer, O., Ludwig, H., Vesole, D., Blade, J., Kyle, R., Westin, J., Weber, D., Bringhen, S., Niesvizky, R., Waage, A., von Lilienfeld-Toal, M., Lonial, S., Morgan, G. J., Orlowski, R. Z., Shimizu, K., Anderson, K. C., Boccadoro, M., Durie, B. G., Sonneveld, P., Hussein, M. A., Int Myeloma Working Grp, [Group Author] (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. LEUKEMIA, 22 (2). pp. 414-423. ISSN 0887-6924

Cavo, M., Attal, M., Gertz, M. A., Giralt, S., Ludwig, H., Morgan, G. J., Anderson, K. C. (2008) Proceedings of an educational symposium at the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation 30 March 2008 Florence, Italy Lenalidomide in multiple myeloma: in pursuit of optimal treatment. LEUKEMIA RESEARCH, 32 (Supple). S1-S24. ISSN 0145-2126

Dignan, F., Gujral, D., Ethell, M., Evans, S., Treleaven, J., Morgan, G., Potter, M. (2007) Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. BONE MARROW TRANSPLANTATION, 40 (1). pp. 79-82. ISSN 0268-3369

Rollinson, S., Smith, A. G., Allan, J. M., Adamson, P. J., Scott, K., Skibola, C. F., Smith, M. T., Morgan, G. J. (2007) RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. LEUKEMIA RESEARCH, 31 (2). pp. 169-174. ISSN 0145-2126

Child, J. A., Morgan, G., Jackson, G. (2005) Response to Goodman et al.: Amyloidosis, not myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 129 (1). pp. 159-160. ISSN 0007-1048

Lightfoot, T. J., Skibola, C. F., Willett, E. V., Skibola, D. R., Allan, J. M., Coppede, F., Adamson, P. J., Morgan, G. J., Roman, E., Smith, M. T. (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 14 (12). pp. 2999-3003. ISSN 1055-9965

Mead, G. P., Carr-Smith, H., Drayson, M. T., Morgan, G., Child, A. J. (2005) Serum free light chains for monitoring multiple myeloma - Response. BRITISH JOURNAL OF HAEMATOLOGY, 128 (3). pp. 406-407. ISSN 0007-1048

Hill, A., Short, M. A., Varghese, C., Kusumakumary, P., Kumari, P., Morgan, G. J. (2005) The t(12 : 21) is underrepresented in childhood B-lineage acute lymphoblastic leukemia in Kerala, Southern India. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 90 (3). pp. 414-416. ISSN 0390-6078

Ross, F. M., Chiecchio, L., Dagrada, G., Protheroe, R. K. M., Stockley, D. M., Harrison, C. J., Cross, N. C. P., Szubert, A. J., Drayson, M. T., Morgan, G. J., UK Myeloma Forum, [Group Author] (2010) The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95 (7). pp. 1221-1225. ISSN 0390-6078

Fenton, J. A. L., Schuuring, E., Barrans, S. L., Banham, A. H., Rollinson, S. J., Morgan, G. J., Jack, A. S., van Krieken, J., Kluin, P. M. (2006) t(r;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma. GENES CHROMOSOMES & CANCER, 45 (2). pp. 164-168. ISSN 1045-2257

Willett, E. V., Smith, A. G., Dovey, G. J., Morgan, G. J., Parker, J., Roman, E. (2004) Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. CANCER CAUSES & CONTROL, 15 (8). pp. 771-780. ISSN 0957-5243

Walker, B. A., Morgan, G. J. (2006) Use of single nucleotide polymorphism-based mapping arrays to detect copy number changes and loss of heterozygosity in multiple myeloma. CLINICAL LYMPHOMA & MYELOMA, 7 (3). pp. 186-191. ISSN 1557-9190

Dignan, F., Alvares, C., Riley, U., Ethell, M., Cunningham, D., Treleaven, J., Ashley, S., Bendig, J., Morgan, G., Potter, M. (2006) Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality. JOURNAL OF HOSPITAL INFECTION, 63 (4). pp. 452-458. ISSN 0195-6701

Morgan, G. J., Krishnan, B., Jenner, M., Davies, F. E. (2006) Advances in oral therapy for multiple myeloma. LANCET ONCOLOGY, 7 (4). pp. 316-325. ISSN 1470-2045

Al Rayes, M. H., Rawstron, A. C., Morgan, G. J., Davies, F. E. (2006) The bone marrow microenvironment influences the differential chemokine receptor expression of normal and neoplastic plasma cells. BLOOD, 105 (12). pp. 4895-4896. ISSN 0006-4971

Wu, P., Davies, F. E., Horton, C., Jenner, M. W., Krishnan, B., Alvares, C. L., Saso, R., McCormack, R., Dines, S., Treleaven, J. G., Potter, M. N., Ethell, M. E., Morgan, G. J. (2006) The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide-vincristine-doxorubicin-methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis. LEUKEMIA & LYMPHOMA, 47 (11). pp. 2335-2338. ISSN 1042-8194

Morgan, G. J., Davies, F. E. (2005) Evolving treatment strategies for myeloma. BRITISH JOURNAL OF CANCER, 92 (2). pp. 217-221. ISSN 0007-0920

Johnson, D. C., Corthals, S., Ramos, C., Hoering, A., Cocks, K., Dickens, N. J., Haessler, J., Goldschmidt, H., Child, J. A., Bell, S. E., Jackson, G., Baris, D., Rajkumar, S. V., Davies, F. E., Durie, B. G. M., Crowley, J., Sonneveld, P., Van Ness, B., Morgan, G. J. (2008) Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. BLOOD, 112 (13). pp. 4924-4934. ISSN 0006-4971

Morgan, G. J., Adamson, P. J., Mensah, F. K., Spink, C. F., Law, G. R., Keen, L. J., Roman, E., Davies, F. E., Rollinson, S., Child, J. A., Bidwell, J. L. (2005) Haplotypes in the tumour necrosis factor region and myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 129 (3). pp. 358-365. ISSN 0007-1048

Palumbo, A., Sezer, O., Kyle, R., Miguel, J. S., Orlowski, R. Z., Moreau, P., Niesvizky, R., Morgan, G., Comenzo, R., Sonneveld, P., Kumar, S., Hajek, R., Giralt, S., Bringhen, S., Anderson, K. C., Richardson, P. G., Cavo, M., Davies, F., Blade, J., Einsele, H., Dimopoulos, M. A., Spencer, A., Dispenzieri, A., Reiman, T., Shimizu, K., Lee, J. H., Attal, M., Boccadoro, M., Mateos, M., Chen, W., Ludwig, H., Joshua, D., Chim, J., Hungria, V., Turesson, I., Durie, B. G. M., Lonial, S., IMWG, [Group Author] (2009) International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. LEUKEMIA, 23 (10). pp. 1716-1730. ISSN 0887-6924

Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., Neri, A., Barlogie, B., Kuehl, W. M., Liebisch, P., Davies, F., Chen-Kiang, S., Durie, B. G. M., Carrasco, R., Sezer, O., Reiman, T., Pilarski, L., Avet-Loiseau, H. (2009) International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. LEUKEMIA, 23 (12). pp. 2210-2221. ISSN 0887-6924

Morgan, G. J., Schey, S. A., Wu, P., Srikanth, M., Phekoo, K. J., Jenner, M., Davies, F. E. (2007) Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients. BRITISH JOURNAL OF HAEMATOLOGY, 137 (3). pp. 268-269. ISSN 0007-1048

Roddam, P. L., Allan, J. M., Dring, A. M., Worrillow, L. J., Davies, F. E., Morgan, G. J. (2010) Non-Homologous End-Joining Gene Profiling Reveals Distinct Expression Patterns Associated with Lymphoma and Multiple Myeloma. BRITISH JOURNAL OF HAEMATOLOGY, 149 (2). pp. 258-262. ISSN 0007-1048

Morgan, G. J., Davies, F. E., Cavenagh, J. D., Jackson, G. H., UKMF, [Group Author], Haematology Oncology Task Force, [Group Author] (2008) Position statement on the use of bortezomib in multiple myeloma. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 30 (1). pp. 1-10. ISSN 1751-5521

Morgan, G. J., Davies, F. E. (2005) Reply to letters on review 'Evolving treatment strategies for myeloma'. BRITISH JOURNAL OF CANCER, 93 (2). p. 269. ISSN 0007-0920

Davies, F., Morris, C., Bird, J., Cook, G., Williams, C., Tighe, J., Cavenagh, J., Behrens, J., Schey, S., Morgan, G., United Kingdom Myeloma Forum, [Group Author] (2009) United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 31 (2). pp. 119-131. ISSN 1751-5521

Davenport, E. L., Morgan, G. J., Davies, F. E. (2008) Untangling the unfolded protein response. CELL CYCLE, 7 (7). pp. 865-869. ISSN 1538-4101

Alvares, C. L., Davies, F. E., Horton, C., Patel, G., Powles, R., Morgan, G. J. (2006) The role of second autografts in the management of myeloma at first relapse. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 91 (1). pp. 141-142. ISSN 0390-6078

Wu, P., Davies, F. E., Boyd, K., Thomas, K., Dines, S., Saso, R. M., Potter, M. N., Ethell, M. E., Shaw, B. E., Morgan, G. J. (2009) The impact of extramedullary disease at presentation on the outcome of myeloma. LEUKEMIA & LYMPHOMA, 50 (2). pp. 230-235. ISSN 1042-8194

Sirohi, B., Powles, R., Cavanagh, J., Oakervee, H., Dyer, P., Rintala, T., Kulkarni, S., Rudin, C., Horton, C., Treleaven, J., Morgan, G. (2007) Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. HEMATOLOGY, 12 (2). pp. 113-115. ISSN 1024-5332

Greipp, P. R., San Miguel, J., Durie, B. G. M., Crowley, J. J., Barlogie, B., Blade, J., Boccadoro, M., Child, J. A., Harousseau, J. L., Kyle, R. A., Lahuerta, J. J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Turesson, I., Westin, J. (2005) International staging system for multiple myeloma. JOURNAL OF CLINICAL ONCOLOGY, 23 (15). pp. 3412-3420. ISSN 0732-183X

Sirohi, B., Powles, R., Lawrence, D., Treleaven, J., Kulkarni, S., Leary, A., Rudin, C., Horton, C., Morgan, G. (2007) An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha 2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha 2b. ANNALS OF ONCOLOGY, 18 (8). pp. 1388-1394. ISSN 0923-7534

Sirohi, B., Powles, R., Treleaven, J., Kulkarni, S., Saso, R., Potter, M., Ethell, M., Morgan, G., Singhal, S., Mehta, J. (2008) The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients. BONE MARROW TRANSPLANTATION, 42 (2). pp. 105-112. ISSN 0268-3369

Sirohi, B., Powles, R., Morgan, G., Treleaven, J., Kulkarni, S., Horton, C., Saso, R., Rolfe, D., Cook, G., Shaw, C., Wass, J. (2007) Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. BONE MARROW TRANSPLANTATION, 39 (2). pp. 115-120. ISSN 0268-3369

Alvares, C. L., Davies, F. E., Horton, C. S., Patel, G., Powles, R., Sirohi, B., Zuha, R., Gatt, A., Saso, R., Treleaven, J. G., Dearden, C. E., Potter, M. N., Ethell, M. E., Morgan, G. J. (2005) Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments. BRITISH JOURNAL OF HAEMATOLOGY, 129 (5). pp. 607-614. ISSN 0007-1048

P

Cairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C. R., Michon, J., Weston, C., Perkins, S. L., Raphael, M., McCarthy, K., Patte, C., FAB LMB96 Int Study Comm, [Group Author] (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. BLOOD, 109 (7). pp. 2736-2743. ISSN 0006-4971

Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S. L., McCarthy, K., Cairo, M. S., FAB LMB96 Int Study Comm, [Group Author] (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. BLOOD, 109 (7). pp. 2773-2780. ISSN 0006-4971

Messahel, B., Taj, M. M., Hobson, R., Hadzic, N., Ramsay, A., Hann, I., Pinkerton, R. (2006) Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review. LEUKEMIA & LYMPHOMA, 47 (12). pp. 2584-2589. ISSN 1042-8194

Hunter, H. M., Peggs, K., Powles, R., Rahemtulla, A., Mahendra, P., Cavenagh, J., Littlewood, T., Potter, M., Hunter, A., Pagliuca, A., Williams, C. D., Cook, G., Towlson, K., Marks, D. I., Russell, N. H. on behalf of the Clinical Trials Committee of the British Society of Blood and Marrow Transplantation (BSBMT) (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRITISH JOURNAL OF HAEMATOLOGY, 128 (4). pp. 496-502. ISSN 0007-1048

Passweg, J. R., Orchard, K., Buergi, A., Gratwohl, A., Powles, R., Goldman, J., Apperley, J., Mehta, J. (2004) Autologous/syngeneic stem cell transplantation to treat refractory GvHD. BONE MARROW TRANSPLANTATION, 34 (11). pp. 995-998. ISSN 0268-3369

Powles, R., Sirohi, B., Kulkarni, S., Treleaven, J., Rudin, C., Sankpal, S., Goyal, S., Horton, C., Millar, B., Saso, R., Singhal, S., Mehta, J. (2002) Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'? BONE MARROW TRANSPLANTATION, 30 (8). pp. 479-484. ISSN 0268-3369

Visani, G., Milligan, D., Leoni, F., Chang, J., Kelsey, S., Marcus, R., Powles, R., Schey, S., Covelli, A., Isidori, A., Litchman, M., Piccaluga, P. P., Mayer, H., Malagola, M., Pfister, C. (2001) Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia. LEUKEMIA, 15 (5). pp. 764-771. ISSN 0887-6924

Sirohi, B., Powles, R., Kulkarni, S., Rudin, C., Saso, R., Lal, R., Singhal, S., Mehta, J., Horton, C., Treleaven, J. (2001) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. BONE MARROW TRANSPLANTATION, 28 (1). pp. 29-37. ISSN 0268-3369

Mehta, J., Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Saso, R., Tait, D., Singhal, S. (2002) Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? BONE MARROW TRANSPLANTATION, 29 (10). pp. 853-859. ISSN 0268-3369

Boriskin, Y. S., Fuller, K., Powles, R. L., Vipond, I. B., Rice, P. S., Booth, J. C., Caul, E. O., Butcher, P. D. (2002) Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. JOURNAL OF CLINICAL VIROLOGY, 24 (1-2). pp. 13-23. ISSN 1386-6532

Sirohi, B., Powles, R., Mehta, J., Rudin, C., Kulkarni, S., Horton, C., Saso, R., Singhal, S., Treleaven, J. (2005) An elective single autograft with high-dose melphalan: single-center study of 451 patients. BONE MARROW TRANSPLANTATION, 36 (1). pp. 19-24. ISSN 0268-3369

Sirohi, B., Powles, R. (2006) Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. EUROPEAN JOURNAL OF CANCER, 42 (11). pp. 1671-1683. ISSN 0959-8049

Sirohi, B., Powles, R., Kulkarni, S., Rudin, C., Saso, R., Rigg, A., Horton, C., Singhal, S., Mehta, J., Treleaven, J. (2001) Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myeloma. BRITISH JOURNAL OF CANCER, 85 (3). pp. 325-332. ISSN 0007-0920

Vaidya, S. J., Ortin, M., Lopez-Duarte, M., Sirohi, B., Powles, R., Treleaven, J., Richard, C. (2005) Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection. LEUKEMIA & LYMPHOMA, 46 (8). pp. 1143-1150. ISSN 1042-8194

Singhal, S., Powles, R., Mehta, J. (2001) Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood. NEW ENGLAND JOURNAL OF MEDICINE, 344 (21). pp. 1641-1642. ISSN 0028-4793

Mehta, J., Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Singhal, S. (2004) High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission. BONE MARROW TRANSPLANTATION, 33 (11). pp. 1107-1114. ISSN 0268-3369

Mehta, J., Powles, R., Sirohi, B., Treleaven, J., Swansbury, G. J., Kulkarni, S., Saso, R., Singhal, S. (2003) Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes? BONE MARROW TRANSPLANTATION, 32 (2). pp. 157-164. ISSN 0268-3369

Sirohi, B., Powles, R., Mehta, J., Treleaven, J., Raje, N., Kulkarni, S., Rudin, C., Bhagwati, N., Horton, C., Saso, R., Singhal, S., Parikh, P. (2001) The implication of compromised renal function at presentation in myeloma - similar outcome in patients who receive high-dose therapy: A single-center study of 251 previously untreated patients. MEDICAL ONCOLOGY, 18 (1). pp. 39-50. ISSN 1357-0560

Powles, R., Apperley, J. (2002) Major radiation exposure. NEW ENGLAND JOURNAL OF MEDICINE, 347 (12). pp. 944-947. ISSN 0028-4793

Sirohi, B., Powles, R. (2004) Multiple myeloma. LANCET, 363 (9412). pp. 875-887. ISSN 0140-6736

Fouillard, L., Labopin, M., Gratwohl, A., Powles, R., Bacigalupo, A., Bego, G., Chesnel, V., Gorin, N. (2002) Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry. BONE MARROW TRANSPLANTATION, 30 (10). pp. 637-643. ISSN 0268-3369

Salooja, N., Szydlo, R. M., Socie, G., Rio, B., Chatterjee, R., Ljungman, P., Van Lint, M. T., Powles, R., Jackson, G., Hinterberger-Fischer, M., Kolb, H. J., Apperley, J. F. (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. LANCET, 358 (9278). pp. 271-276. ISSN 0140-6736

Sirohi, B., Powles, R., Rudin, C., Singhal, S., Kulkarni, S., Saso, R., Horton, C., Mehta, J., Treleaven, J. (2005) Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. HEMATOLOGY, 10 (5). pp. 361-364. ISSN 1024-5332

Sirohi, B., Powles, R., Kulkarni, S., Rudin, C., Frassoni, F., Bacigalupo, A., Singhal, S., Vaidya, S., Labopin, M., Michallet, M., Blaise, D., Reiffers, J., Meloni, G., Rio, B., Treleaven, J., Horton, C., Mehta, J. (2004) Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cells. BONE MARROW TRANSPLANTATION, 33 (12). pp. 1209-1214. ISSN 0268-3369

Singhal, S., Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Mehta, J. (2002) Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. BONE MARROW TRANSPLANTATION, 30 (10). pp. 673-679. ISSN 0268-3369

Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Tait, D., Singhal, S., Mehta, J. (2002) The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. BLOOD, 100 (5). pp. 1641-1647. ISSN 0006-4971

Sirohi, B., Kulkarni, S., Powles, R. (2001) Some early phase II trials in previously untreated multiple myeloma: The Royal Marsden experience. SEMINARS IN HEMATOLOGY, 38 (3). pp. 209-218. ISSN 0037-1963

Kroger, N., Brand, R., van Biezen, A., Bron, D., Blaise, D., Hellstrom-Lindberg, E., Gahrton, G., Powles, R., Littlewood, T., Chapuis, B., Zander, A., Koza, V., Niederwieser, D., de Witte, T. for the Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Blood and Marrow Transplantation Group (2005) Stem cell transplantation from identical twins in patients with myelodysplastic syndromes. BONE MARROW TRANSPLANTATION, 35 (1). pp. 37-43. ISSN 0268-3369

Sirohi, B., Powles, R. L., Chopra, R., Russell, N., Byrne, J. L., Prentice, H. G., Potter, M., Koblinger, S. (2006) A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION, 38 (1). pp. 47-51. ISSN 0268-3369

Mitchell, P., Lee, F. T., Hall, C., Rigopoulos, A., Smyth, F. E., Hekman, A. M., van Schijndel, G. M., Powles, R., Brechbiel, M. W., Scott, A. M. (2003) Targeting primary human Ph+ B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies. JOURNAL OF NUCLEAR MEDICINE, 44 (7). pp. 1105-1112. ISSN 0161-5505

Abdou, S. M. H., Jadayel, D. M., Min, T., Swansbury, G. J., Dainton, M. G., Jafer, O., Powles, R. L., Catovsky, D. (2002) Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia. LEUKEMIA & LYMPHOMA, 43 (1). pp. 89-95. ISSN 1042-8194

Harousseau, J. L., Mundy, G. R., Durie, B., Powles, R., Catovsky, D., Kulkarni, S., Dowsett, M., Goyal, S. (2001) International grand round. Myeloma Grand Round. LANCET ONCOLOGY, 2 (9). pp. 571-579. ISSN 1470-2045

Sirohi, B., Powles, R., Singhal, S., Smith, K., Jones, R. L., Saso, R., Kulkarni, S., Treleaven, J., Swansbury, G. J., Potter, M., Morgan, G., Mehta, J. (2008) Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. LEUKEMIA & LYMPHOMA, 49 (12). pp. 2284-2290. ISSN 1042-8194

Singhal, S., Powles, R., Henslee-downey, P. J., Chiang, K. Y., Treleaven, J., Godder, K., Kulkarni, S., van Rhee, S., Sirohi, B., Pinkerton, C. R., Meller, S., Mehta, J. (2002) Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. BONE MARROW TRANSPLANTATION, 29 (4). pp. 291-295. ISSN 0268-3369

Singhal, S., Henslee-Downey, P. J., Powles, R., Chiang, K. Y., Godder, K., Treleaven, J., Kulkarni, S., van Rhee, F., Sirohi, B., Pinkerton, C. R., Meller, S., Jovanovic, B., Mehta, J. (2003) Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. BONE MARROW TRANSPLANTATION, 31 (10). pp. 889-895. ISSN 0268-3369

Kulkarni, S., Powles, R., Sirohi, B., Treleaven, J., Saso, R., Horton, C., Atra, A., Ortin, M., Rudin, C., Goyal, S., Sankpal, S., Meller, S., Pinkerton, C. R., Mehta, J., Singhal, S. (2003) Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. BONE MARROW TRANSPLANTATION, 32 (2). pp. 165-170. ISSN 0268-3369

Sellick, G. S., Pritchard-Jones, K., Shepherd, V., Swansbury, J., Catovsky, D., Houlston, R. S. (2005) Loci other than 21q22.12 (RUNX1) and 16q21-23.2 cause familial AML. LEUKEMIA, 19 (3). pp. 465-466. ISSN 0887-6924

R

Okines, A. F. C., Reynolds, A. R., Cunningham, D. (2011) Targeting Angiogenesis in Esophagogastric Adenocarcinoma. ONCOLOGIST, 16 (6). pp. 844-858. ISSN 1083-7159

S

Querol, S., Mufti, G. J., Marsh, S. G. E., Pagliuca, A., Little, A. M., Shaw, B. E., Jeffery, R., Garcia, J., Goldman, J. M., Madrigal, J. A. (2009) Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 94 (4). pp. 536-541. ISSN 0390-6078

Dignan, F. L., Manwani, R., Potter, M. N., Ethell, M. E., Leonard, H., Brennan, J., Baker, J., Shaw, B. E. (2013) A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. CLINICAL TRANSPLANTATION, 27 (1). E1-E2. ISSN 0902-0063

Patel, B., Kirkland, K. E., Szydlo, R., Pearce, R. M., Clark, R. E., Craddock, C., Liakopoulou, E., Fielding, A. K., Mackinnon, S., Olavarria, E., Potter, M. N., Russell, N. H., Shaw, B. E., Cook, G., Goldstone, A. H., Marks, D. I. (2009) Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 94 (10). pp. 1399-1406. ISSN 0390-6078

Shaw, B. E., Arguello, R., Garcia-Sepulveda, C. A., Madrigal, J. A. (2010) The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY, 150 (3). pp. 251-258. ISSN 0007-1048

Shaw, B. E., Gooley, T. A., Malkki, M., Madrigal, J. A., Begovich, A. B., Horowitz, M. M., Gratwohl, A., Ringden, O., Marsh, S. G. E., Petersdorf, E. W. (2007) The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. BLOOD, 110 (13). pp. 4560-4566. ISSN 0006-4971

Scarisbrick, J. J., Dignan, F. L., Tulpule, S., Gupta, E. D., Kolade, S., Shaw, B., Evison, F., Shah, G., Tholouli, E., Mufti, G., Pagliuca, A., Malladi, R., Raj, K. (2015) A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent. BONE MARROW TRANSPLANTATION, 50 (1). pp. 62-67. ISSN 0268-3369

Shaw, B. E., Mufti, G. J., Mackinnon, S., Cavenagh, J. D., Pearce, R. M., Towlson, K. E., Apperley, J. F., Chakraverty, R., Craddock, C. F., Kazmi, M. A., Littlewood, T. J., Milligan, D. W., Pagliuca, A., Thomson, K. J., Marks, D. I., Russell, N. H. (2008) Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. BONE MARROW TRANSPLANTATION, 42 (12). pp. 783-789. ISSN 0268-3369

Billen, A., Madrigal, J. A., Strydom, A., Szydlo, R. M., Switzer, G. E., Shaw, B. E. (2015) Predonation Health-Related Quality of Life Scores Predict Time to Recovery in Hematopoietic Stem Cell Donors. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21 (2). pp. 350-356. ISSN 1083-8791

Shaw, B. E., Veys, P., Pagliuca, A., Addada, J., Cook, G., Craddock, C. F., Gennery, A. R., Goldman, J., Mackinnon, S., Madrigal, J. A., Marks, D. I., Navarrete, C., Potter, M. N., Querol, S., Regan, F., Russell, N. H., Hough, R. E. (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. BONE MARROW TRANSPLANTATION, 44 (1). pp. 7-12. ISSN 0268-3369

Billen, A., Madrigal, J. A., Shaw, B. E. (2014) A review of the haematopoietic stem cell donation experience: is there room for improvement? BONE MARROW TRANSPLANTATION, 49 (6). pp. 729-736. ISSN 0268-3369

Tulpule, S., Shaw, B. E., Makoni, P., Little, A., Madrigal, J. A., Goldman, J. M. (2009) Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. BONE MARROW TRANSPLANTATION, 44 (2). pp. 129-130. ISSN 0268-3369

Shaw, B. E., Russell, N. H. (2008) Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. BONE MARROW TRANSPLANTATION, 41 (5). pp. 495-503. ISSN 0268-3369

Dignan, F. L., Evans, S. O., Ethell, M. E., Shaw, B. E., Davies, F. E., Dearden, C. E., Treleaven, J. G., Riley, U. B. G., Morgan, G. J., Potter, M. N. (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPLANTATION, 44 (1). pp. 51-56. ISSN 0268-3369

Summersgill, B., Thornton, P., Atkinson, S., Matutes, E., Shipley, J., Catovsky, D., Houlston, R. S., Yuille, M. R. (2002) Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis. LEUKEMIA, 16 (7). pp. 1229-1232. ISSN 0887-6924

Gruszka-Westwood, A. M., Atkinson, S., Summersgill, B. M., Shipley, J., Elnenaei, M. O., Jain, P., Hamoudi, R. A., Kaeda, J. S., Wotherspoon, A. C., Matutes, E., Catovsky, D. (2002) Unusual case of leukemic mantle cell lymphoma with amplified CCNDI/IGH fusion gene. GENES CHROMOSOMES & CANCER, 33 (2). pp. 206-212. ISSN 1045-2257

Swerdlow, A. J., Higgins, C. D., Smith, P., Cunningham, D., Hancock, B. W., Horwich, A., Hoskin, P. J., Lister, A., Radford, J. A., Rohatiner, A. Z. S., Linch, D. C. (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 99 (3). pp. 206-214. ISSN 0027-8874

Swerdlow, A. J., Schoemaker, M. J., Allerton, R., Horwich, A., Barber, J. A., Cunningham, D., Lister, T. A., Rohatiner, A. Z. S., Vaughan Hudson, G., Williams, M. V., Linch, D. C. (2001) Lung cancer after Hodgkin's disease: a case-control study of the relation to treatment. JOURNAL OF CLINICAL ONCOLOGY, 19 (6). pp. 1610-1618. ISSN 0732-183X

T

Griessinger, E., Vargaftig, J., Horswell, S., Taussig, D. C., Gribben, J., Bonnet, D. (2018) Acute myeloid leukemia xenograft success prediction: Saving time. EXPERIMENTAL HEMATOLOGY, 59. pp. 66-71. ISSN 0301-472X

Addada, J., Anoop, P., Swansbury, J. G., Wotherspoon, A., Thomas, J. M., Matutes, E. (2010) Synchronous Mantle Cell Lymphoma, Chronic Lymphocytic Leukaemia and Melanoma in a Single Lymph Node. ACTA HAEMATOLOGICA, 123 (3). pp. 194-196. ISSN 0001-5792

W

Davenport, E. L., Moore, H. E., Dunlop, A. S., Sharp, S. Y., Workman, P., Morgan, G. J., Davies, F. E. (2007) Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. BLOOD, 110 (7). pp. 2641-2649. ISSN 0006-4971